Literature DB >> 1183857

Assessment of severity in colitis: a preliminary study.

J E Lennard-Jones, J K Ritchie, W Hilder, C C Spicer.   

Abstract

Clinical features, alone and in combinations of up to five, noted early in patients during 181 admissions to one hospital for treatment of acute colitis over five years, have been correlated with the success or failure of drug treatment as judged by death during medical treatment or the need for urgent surgical treatment. Many of the 56 clinical features studied were of no value in predicting the outcome of the attack. The four features of greatest predictive value were the maximum daily body temperature, the maximum daily pulse rate, the bowel frequency and plasma albumin. The simplest and most discriminating prediction at the end of the first 24 hours in hospital was obtained by combining observations on maximum body temperature and the number of stools passed. Serial observations of temperature or pulse rate over the first four days in hospital gave more prognostic information than observations confined to the first day. The predictive value of certain other features, such as x-ray appearances, is described. A simple classification of severity in acute colitis is proposed from these results as a basis for prospective testing in other hospitals.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1183857      PMCID: PMC1411009          DOI: 10.1136/gut.16.8.579

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

2.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

3.  Discriminant and Bayes analysis in the differential diagnosis of Crohns disease and proctocolitis.

Authors:  C C Spicer; J H Jones; J E Jones
Journal:  Methods Inf Med       Date:  1973-04       Impact factor: 2.176

4.  Ulcerative colitis. A clinical study of 399 patients.

Authors:  K N Jalan; R F Prestcott; W Sircus; W I Card; J P McManus; C W Falconer; W P Small; A N Smith; J Bruce
Journal:  J R Coll Surg Edinb       Date:  1971-11

5.  Radiological appearances of ulcerative colitis: an evaluation of their clinical significance.

Authors:  F T De Dombal; N Geffen; A Darnborough; G Watkinson; J C Goligher
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

6.  An experience of ulcerative colitis. II. Short term outcome.

Authors:  K N Jalan; R J Prescott; W Sircus; W I Card; J P McManus; C W Falconer; W P Small; A N Smith; J Bruce
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

7.  Early course of ulcerative colitis.

Authors:  J M Watts; F T De Dombal; G Watkinson; J C Goligher
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

8.  Results of surgery for inflammatory bowel disease: a further survey of one hospital region.

Authors:  J K Ritchie
Journal:  Br Med J       Date:  1974-02-16
  8 in total
  39 in total

1.  Refractory Inflammatory Bowel Disease.

Authors:  Thomas A. Judge; Gary R. Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

2.  Blood pH: a test for assessment of severity in proctocolitis.

Authors:  R Caprilli; P Vernia; O Colaneri; A Torsoli
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

Review 3.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

4.  Fulminant colitis.

Authors:  Bruce E Sands
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

5.  Serum lysozyme in inflammatory bowel and coeliac disease.

Authors:  E Mallas; J M Terry; P Asquith; W T Cooke
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

6.  Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.

Authors:  J Rüthlein; M Ibe; W Burghardt; J Mössner; I O Auer
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

7.  Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States.

Authors:  Rajkumar Doshi; Jiten Desai; Yash Shah; Dean Decter; Shreyans Doshi
Journal:  Intern Emerg Med       Date:  2018-06-12       Impact factor: 3.397

Review 8.  MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE.

Authors:  Carlos Walter Sobrado; Lucas Faraco Sobrado
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

Review 9.  [What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases].

Authors:  M Bartels; E Nagel; R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1995

10.  Infliximab in ulcerative colitis.

Authors:  Avi Levin; Oren Shibolet
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.